Literature DB >> 10653979

The proteasome controls the expression of a proliferation-associated nuclear antigen Ki-67.

Y Wu1, H Luo, N Kanaan, J Wu.   

Abstract

The proteasome is a protease complex responsible for rapid, selective, and irreversible removal of regulatory proteins, as well as many other cellular proteins. In this study, we have demonstrated that a proliferation-associated nuclear protein Ki-67 depended on the proteasome for its rapid degradation. A proteasome-specific inhibitor lactacystin augmented Ki-67 protein levels in pancreatic cancer BxPC-3 cells while repressed the level of steady-state Ki-67 mRNA. Inhibition of the proteasome also led to accumulation of two CDK inhibitors p27(kip1) and p21(cip1) in the BxPC-3 cells. Failed reduction of Ki-67 protein and enhanced levels of the two CDK inhibitors are likely contributing factors for the suppressed BxPC-3 proliferation after proteasome inhibition. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10653979

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  6 in total

Review 1.  The proteasome: a novel target for anticancer therapy.

Authors:  C Montagut; A Rovira; J Albanell
Journal:  Clin Transl Oncol       Date:  2006-05       Impact factor: 3.405

2.  Proteasome inhibitors induce growth inhibition and apoptosis in myeloma cell lines and in human bone marrow myeloma cells irrespective of chromosome 13 deletion.

Authors:  Ivana Zavrski; Cord Naujokat; Kathrin Niemöller; Christian Jakob; Ulrike Heider; Corinna Langelotz; Claudia Fleissner; Jan Eucker; Kurt Possinger; Orhan Sezer
Journal:  J Cancer Res Clin Oncol       Date:  2003-07-08       Impact factor: 4.553

Review 3.  Predicting prognosis in gastroentero-pancreatic neuroendocrine tumors: an overview and the value of Ki-67 immunostaining.

Authors:  Mina Jamali; Runjan Chetty
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

4.  Synthesis and evaluation of tiaprofenic acid-derived UCHL5 deubiquitinase inhibitors.

Authors:  Harshani S Gurusingha Arachchige; Poornima D H Herath Mudiyanselage; Garrett C VanHecke; Kush Patel; Hassan A Cheaito; Q Ping Dou; Young-Hoon Ahn
Journal:  Bioorg Med Chem       Date:  2020-12-09       Impact factor: 3.641

5.  Cell Proliferation (KI-67) Expression Is Associated with Poorer Prognosis in Nigerian Compared to British Breast Cancer Women.

Authors:  Ayodeji O J Agboola; Adekumbiola A F Banjo; Charles C Anunobi; Babatunde Salami; Mopelola Deji Agboola; Adewale A Musa; Christopher C Nolan; Emad A Rakha; Ian O Ellis; Andrew R Green
Journal:  ISRN Oncol       Date:  2013-04-11

6.  Potential role of proteasome on c-jun related signaling in hypercholesterolemia induced atherosclerosis.

Authors:  Erdi Sozen; Betul Karademir; Burak Yazgan; Perinur Bozaykut; Nesrin Kartal Ozer
Journal:  Redox Biol       Date:  2014-02-22       Impact factor: 11.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.